Wms Partners, LLC Soligenix, Inc. Transaction History

Wms Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	BUY	$0.61 - $0.75 $15,250 - $18,750	25,000 New	25,000 $18,000
Q4 2021 Feb 14, 2022	SELL	$0.66 - $1.1 $16,500 - $27,500	-25,000 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$1.42 - $3.34 $35,500 - $83,500	25,000 New	25,000 $42,000

Ticker SNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,105,200
Market Cap $117M
Description
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...

Get notified when there are updates to the investment portfolio of Wms Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Wms Partners, LLC with notifications on news.